PALAMEDRIX
Palamedrix is a developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company utilizes DNA nanotechnology to procure solutions for biomedical applications by providing comprehensive data. Palamedrix was established in 2017 by Shane Bowen in San Diego, California.
PALAMEDRIX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.palamedrix.com
Total Employee:
1+
Status:
Active
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache
Similar Organizations
Epirium Bio
Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Cellics Therapeutics
Cellics is committed to saving lives and improving patientsโ health using innovative biomimetic nanomedicines.
Jengu Therapeutics
Jengu Therapeutics is a biotech company focuses on cellular signaling pathways regulating normal cell proliferation and differentiation.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Casdin Capital
Casdin Capital investment in Seed Round - Palamedrix
FoundersX Ventures
FoundersX Ventures investment in Seed Round - Palamedrix
Official Site Inspections
http://www.palamedrix.com Semrush global rank: 4.33 M Semrush visits lastest month: 2.63 K
Unable to get host informations!!!
More informations about "Palamedrix"
Palamedrix Company Profile 2024: Valuation, Investors โฆ
Palamedrix General Information Description. Developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company's platform leverages DNA nanotechnology to develop solutions for โฆSee details»
Palamedrix - VentureRadar
Palamedrix is the first company to leverage DNA nanotechnology for revolutionary advancements in life science and medicine. By utilizing biosensors engineered to capture small molecules โฆSee details»
Palamedrix - Products, Competitors, Financials, Employees, โฆ
Palamedrix is a DNA nanotechnology company that develops a multi-omic platform designed to accelerate advancements in life science and medicine. Use the CB Insights Platform to โฆSee details»
Palamedrix, Inc. Company Profile | La Jolla, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Palamedrix, Inc. of La Jolla, CA. Get the latest business insights from Dun & Bradstreet.See details»
Palamedrix - Ownership and Business Overview - Mergr
Jul 26, 2022 Palamedrix is a developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company's platform leverages DNA โฆSee details»
Palamedrix - Company Profile - Tracxn
Oct 22, 2024 Palamedrix ranks 131st among 425 active competitors. 80 of its competitors are funded while 36 have exited. Overall, Palamedrix and its competitors have raised over $4.64B โฆSee details»
Palamedrix - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 1, 2021: Seed Round - โฆSee details»
SomaLogic acquires Palamedrix - 2022-07-26 - Crunchbase
Jul 27, 2022 Palamedrix Palamedrix leverages DNA nanotechnology for advancements in life science and medicine. Acquiring Organization: SomaLogic SomaLogic is a protein biomarker โฆSee details»
SomaLogic, Inc. completed the acquisition of Palamedrix, Inc.
Aug 30, 2022 The Palamedrix team will continue to work from the company's La Jolla-based offices and lab space. The transaction is expected to close in the third quarter of 2022. Cowen โฆSee details»
SomaLogic acquires DNA nanotechnology leader Palamedrix to
Jul 26, 2022 Palamedrixโs technology uses DNA-based biosensors that capture small molecules present in biological samples to pinpoint the presence of any analyte with single-molecule โฆSee details»
SomaLogic acquires DNA nanotechnology leader Palamedrix to โฆ
Aug 1, 2022 SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in โฆSee details»
Palamedrix - Crunchbase
Palamedrix leverages DNA nanotechnology for advancements in life science and medicine.See details»
Palamedrix | Nanotechnology Company | NPD - STATNANO
Palamedrix is a DNA nanotechnology based company building a disruptive tool for life sciences and medicine. By utilizing biosensors engineered to capture small molecules present in โฆSee details»
SomaLogic acquires DNA nanotechnology leader Palamedrix to โฆ
Jul 26, 2022 Brings differentiated miniaturization technology, scientific and engineering expertise, and enhanced ease-of-use capabilities to SomaLogicโs platform while expanding โฆSee details»
SomaLogic to Acquire DNA Nanotech Firm Palamedrix for up to
Jul 26, 2022 Palamedrix, based in San Diego, has developed DNA nanotechnology that allows it to build arrays of DNA biosensors that can measure proteins and other analytes with single โฆSee details»
Palamedrix - Contacts, Employees, Board Members, Advisors
Palamedrix leverages DNA nanotechnology for advancements in life science and medicine.See details»
SomaLogic Acquires DNA Nanotechnology Leader Palamedrix to โฆ
Aug 1, 2022 Palamedrixโs technology uses DNA-based biosensors that capture small molecules present in biological samples to pinpoint the presence of any analyte with single-molecule โฆSee details»
Palamedrix - Updates, News, Events, Signals & Triggers - Crunchbase
Mar 1, 2021 Organization. Palamedrix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Funding Round โข Mar 1, 2021. Palamedrix raised $6,000,000 / โฆSee details»
SomaLogic Says Palamedrix Technology Could Enable More โฆ
Jul 27, 2022 NEW YORK โ With its recently announced acquisition of San Diego-based DNA nanotechnology firm Palamedrix for up to $52.5 million, SomaLogic aims to develop more โฆSee details»